PCMC
ALT icon

Planning Capital Management Corporation’s Altimmune ALT Stock Holding History

Planning Capital Management Corporation’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$676 Hold
110
– – ﹤0.01% 655
2024
Q2 		$732 Buy
+110
New +$812 ﹤0.01% 602

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Planning Capital Management Corporation's ALT Position: Q3 2024 in Review

Planning Capital Management Corporation held its Altimmune (ALT) position steady in Q3 2024 at 110 shares worth $676. The position accounts for ﹤0.01% of the portfolio, ranked #655.

Planning Capital Management Corporation first reported a position in ALT in Q2 2024 and has held it in 2 quarters since. The position peaked at $732 in Q2 2024. 169 funds tracked by Wall St. Rank hold ALT as of Q3 2024.

  • Planning Capital Management Corporation held 110 shares of Altimmune worth $676 as of Q3 2024.
  • Planning Capital Management Corporation left its Altimmune share count unchanged in Q3 2024.
  • Altimmune made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #655 holding.
  • Planning Capital Management Corporation first reported a position in Altimmune in Q2 2024 and has held it in 2 quarters since.
  • Planning Capital Management Corporation's Altimmune position peaked at $732 in Q2 2024.
  • 169 funds tracked by Wall St. Rank held Altimmune as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.